What does this LOINC code represent?

This LOINC code identifies a lab observation, measurement, question, or clinical concept in a standardized format.

Is this enough to understand my test result?

No. The code identifies the test or observation, but the interpretation depends on the actual result, reference range, and clinical context.

LOINCActiveBoth

LOINC Code 75573-6: Comment on Triploidy risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA) [Interp]

Name: LOINC Code 75573-6: Comment on Triploidy risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA) [Interp]
Creator: HealthAssure Clinical Team
Published: 2026-05-21T08:59:55.159Z

75573-6 is a LOINC code used to identify Comment on Triploidy risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA) [Interp] in laboratory and clinical observation data. You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges. LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Comment on fetal Triploidy risk. It is commonly used with the system or sample type WBC.DNA+Plas.cfDNA.

Reviewed by HealthAssure Clinical TeamUpdated 21 May 2026

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Comment on fetal Triploidy risk. It is commonly used with the system or sample type WBC.DNA+Plas.cfDNA.

When is it used?

Used in lab systems, EHRs, and clinical data exchange.
May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
Status: ACTIVE
Order vs observation: Both
Method: Dosage of chromosome specific cf DNA

What it does not mean

The code identifies the observation or test, not the actual result.

Key facts

Comment on fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA Narrative
Comment on fetal Triploidy risk
Chromosom; Chromosomes; cmmt; cmnt; Com; Comm; Comments; Commt; Fet Triploidy risk comment; Genetics; Heredity; Heritable; Impression; Impression/interpretation of study; Impressions; Inherited; Interp; Interpretation; Leukocytes; Molecular pathology; MOLPATH; MOLPATH.TRISOMY; Narrative; Pl; Plasma; Plsm; Point in time; Random; Remarks; Report; Spec; Trip risk; Ts; WBC.DNA+cfDNA; WBCs; White blood cells

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Comment on Triploidy risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA) [Interp]Comment on fetal Triploidy risk [Interpretation] based on Plasma cell-free+WBC DNA by Dosage of chromosome-specific cfDNA NarrativeFet Triploidy risk commentComment on fetal Triploidy riskMOLPATH.TRISOMYImpPt

Frequently asked questions

Code details

Code75573-6

SystemLOINC

Display nameComment on Triploidy risk Dosage of chromosome-specific cfDNA Nar (Plasma cell-free+WBC DNA) [Interp]

DescriptionComment on fetal Triploidy risk

Short nameFet Triploidy risk comment

ComponentComment on fetal Triploidy risk

PropertyImp

TimingPt

System (specimen)WBC.DNA+Plas.cfDNA

ScaleNar

MethodDosage of chromosome specific cf DNA

ClassMOLPATH.TRISOMY

StatusACTIVE

Order/ObservationBoth

Flags

BillableNo

Valid clinical useNo

Source

SourceLOINC

Version2.82

Releasemain

First released2.50

Last changed2.73

Consumer names

Comment on fetal triploidy risk

Part names

Comment on fetal Triploidy riskImpPtWBC.DNA+Plas.cfDNANarDosage of chromosome specific cf DNAImpression/interpretation of studyPoint in time (spot)Plasma cell-free+WBC DNADosage of chromosome-specific cfDNA

About this content

This page is prepared by HealthAssure's clinical team using official coding standards from LOINC. AI tools assist with drafting explanations, which are then reviewed and verified by healthcare professionals for accuracy. This content is for informational purposes and does not replace professional medical advice. Meet our team.